UroGen Pharma (URGN)

• Market cap: $485M
• 1 day: -5.98%
• 5 days: -8.20%
• 1 month: 13.59%
• 3 months: -6.07%
• 6 months: -14.94%
• Year to date: -1.59%
• 1 year: -22.91%
• 5 years: -42.68%
• 10 years: -24.68%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

302% more call options, than puts

Call options by funds: $896K | Put options by funds: $223K

300% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 4 (+3) [Q4]

50% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 20

8% more funds holding

Funds holding: 128 [Q3] → 138 (+10) [Q4]

2.38% more ownership

Funds ownership: 83.58% [Q3] → 85.96% (+2.38%) [Q4]

8% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 39

14% less capital invested

Capital invested by funds: $447M [Q3] → $386M (-$60.3M) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $25 137% upside
• Avg. target: $37 251% upside
• High target: $55 422% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

D. Boral Capital Jason Kolbert 30% 1-year accuracy 3 / 10 met price target	137% upside $25	Buy Maintained	13 Mar 2025
HC Wainwright & Co. Raghuram Selvaraju 26% 1-year accuracy 18 / 70 met price target	422% upside $55	Buy Maintained	11 Mar 2025
Ladenburg Thalmann Aydin Huseynov 0 / 0 met price target	194% upside $31	Buy Assumed	19 Feb 2025